4JQ1
AKR1C2 complex with naproxen
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-09-29 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.9537 |
Spacegroup name | H 3 2 |
Unit cell lengths | 142.519, 142.519, 205.773 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 105.800 - 1.600 |
R-factor | 0.1942 |
Rwork | 0.192 |
R-free | 0.23633 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | in-house unliganded |
RMSD bond length | 0.023 |
RMSD bond angle | 1.995 |
Data reduction software | XDS |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 105.800 | 1.690 |
High resolution limit [Å] | 1.600 | 1.600 |
Number of reflections | 98708 | |
<I/σ(I)> | 19.1 | |
Completeness [%] | 93.8 | 69 |
Redundancy | 16.5 | 5.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 291 | 20% PEG 3350, 0.2 M diammonium-L-tartrate, VAPOR DIFFUSION, SITTING DROP, temperature 291K |